A Comprehensive Mixed-Methods Evaluation of Botswana's National Antiretroviral Th

博茨瓦纳国家抗逆转录病毒疗法的综合混合方法评估

• 批准号: 8261804
• 负责人: Oathokwa Mooketsana Nkomazana
• 金额: $ 50万
• 依托单位: UNIVERSITY OF BOTSWANA
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-07-01 至 2017-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8261804
• 关键词: Comprehensive; Mixed; Methods; Evaluation; Botswana

Abstract / Summary Botswana has been a leader in galvanizing an effective regional and global response to the epidemic. Despite being one of the countries hardest hit by HIV/AIDS, Botswana was one of the first countries in Africa to provide free universal public antiretroviral therapy (ART) for eligible citizens. Through proactive policies and programs around HIV/AIDS, Botswana has made major gains and has laid the foundation for continued progress against the epidemic. Evaluation of strategic information is necessary to inform the construction, implementation, scale up, and improvement of sustainable programs upon that foundation, while making the best i use of a set of constrained resources. As the national response matures, new priorities have emerged for Botswana's National ART Program, known as Masa, the Setswana word for "new dawn." These priorities include improving patient outcomes and ensuring the long-term financial sustainability of the program, while maintaining adequate health system performance and patient satisfaction. The proposed study directly addresses these priorities through a comprehensive, mixed methods, and sub-national evaluation which makes use of a rich, longitudinal national registry of Masa patient data, in combination with additional survey data. The proposed study will be conducted by a consortium between the University of Botswana School of Medicine (UB SOM), the Harvard School of Public Health (HSPH) and the Botswana Ministry of Health (MOH). i Sanders D, Haines A. (2006). Implementation research is needed to achieve international health goals. PLoS Med, 3(6): e186.

摘要/摘要 博茨瓦纳一直是推动区域和全球有效应对 这场流行病。尽管博茨瓦纳是受艾滋病毒/艾滋病影响最严重的国家之一，但它是 非洲第一个提供免费公共抗逆转录病毒疗法(ART)的国家 符合条件的公民。通过围绕艾滋病毒/艾滋病的积极政策和方案，博茨瓦纳 取得了重大进展，为继续抗击这一流行病奠定了基础。 对战略信息的评估是必要的，以告知建设、实施、 在此基础上扩大和改进可持续方案，同时最大限度地发挥 我 使用一组受限制的资源。随着国家应对措施的成熟，新的优先事项 出现在博茨瓦纳的国家艺术计划，也就是众所周知的Masa，在茨瓦纳语中意为“新” 这些优先事项包括改善患者的预后和确保长期 方案的财务可持续性，同时保持适当的卫生系统业绩 和病人的满意度。拟议的研究通过一项 综合、混合的方法，以及利用丰富的、 MASA患者数据的纵向全国登记，并结合其他调查数据。 这项拟议的研究将由博茨瓦纳大学 医学院(UB SOM)、哈佛公共卫生学院(HSPH)和博茨瓦纳 卫生部(MOH)。 我 桑德斯·D，海恩斯·A(2006)。需要开展实施研究，以实现国际健康 目标。PLOS Med，3(6)：e186。